The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Seven-year (yr) follow-up of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC).
 
Sara M. Tolaney
Research Funding - Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
William Thomas Barry
Consulting or Advisory Role - ARMO BioSciences
Research Funding - Pfizer (Inst)
 
Hao Guo
No Relationships to Disclose
 
Deborah Dillon
No Relationships to Disclose
 
Chau T. Dang
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - Genentech
 
Denise A. Yardley
No Relationships to Disclose
 
Beverly Moy
Consulting or Advisory Role - MOTUS (I)
 
P. Kelly Marcom
No Relationships to Disclose
 
Kathy S. Albain
No Relationships to Disclose
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Bayer; Novartis; OBI Pharma; Pfizer; Roche/Genentech
 
Matthew James Ellis
Employment - Bioclassifier
Leadership - Bioclassifier
Stock and Other Ownership Interests - Bioclassifier
Consulting or Advisory Role - AstraZeneca; Celgene; NanoString Technologies; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Patent on PAM50, which generates royalties on the license to Bioclassifier/Prosigna/Nanostring
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Iuliana Shapira
No Relationships to Disclose
 
Antonio C. Wolff
Consulting or Advisory Role - Pfizer
Research Funding - Myriad Genetics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.
 
Lisa A. Carey
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst)
 
Beth Overmoyer
No Relationships to Disclose
 
Ann H. Partridge
No Relationships to Disclose
 
Clifford A. Hudis
Consulting or Advisory Role - Lilly; Merck; Novartis; Pfizer; Roche/Genentech
Other Relationship - Breast Cancer Research Foundation
 
Ian E. Krop
Employment - AMAG Pharmaceuticals (I)
Leadership - AMAG Pharmaceuticals (I)
Stock and Other Ownership Interests - AMAG Pharmaceuticals (I)
Research Funding - Genentech
 
Harold J. Burstein
No Relationships to Disclose
 
Eric P. Winer
Consulting or Advisory Role - Genentech/Roche; Leap Therapeutics; Novartis; Verastem
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche